Treatment of Acute Myeloid Leukemia with 20-30% blasts in patients who are not eligible for Haemopoietic stem cell transplant.
Intermediate-2 and High-risk Myelodysplastic syndrome (MDS).
Therapeutic Effects:
The active form of Azadual 100mg Injection binds to RNA and DNA, interrupts their activity in actively multiplying cells, and exhibits a toxic effect on cancer cells.
Interaction with other drugs:
Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Azadual 100 mg injection and cause undesirable side effects.
Storage:
Store at room temperature (15-30°C).
If the product is reconstituted, it must be used immediately; if not, store at 2-8°C for not more than 8 hours.
Keep the injection out of sight and reach of children.
Administration:
Take Azadual 100mg Injection only under the supervision of your physician.
Your physician will decide the dose based on your height, weight, and general condition.
It shall be given under the skin of your thigh, stomach, or upper arm.
Safety Advices:
Pregnancy: Azadual 100mg Injection could be harmful to the unborn fetus. Inform your physician if you are pregnant or planning to get pregnant.
Breastfeeding: Breastfeeding is not intended for patients on Azadual 100mg Injection therapy. Consult your physician for advice.
Lungs: It is not known whether it is safe to administer Azadual 100mg Injection in lung failure patients. Please consult your doctor.
Liver: Inform your physician if you have been told that you have a tumor in the liver cells.
Alcohol: It is not known whether it is safe to consume alcohol with Azadual 100mg Injection. Please consult your doctor.
Driving: It is unsafe to drive after taking this injection as it causes dizziness and patients lack concentration and alertness. So, avoid driving and handling heavy machinery after taking Azadual 100 mg injection.
Side Effects:
Serious: unexpected bleeding, fever, pneumonia, allergic reaction, seizures, loss of consciousness, severe headache, or bleeding in the brain, frequent urination with pain or burning sensation.
Common: disturbances in the blood count (RBC, WBC, Platelets), nausea, vomiting, diarrhea, constipation, tiredness, skin reactions like redness and pain at the site of injection, decreased appetite, dizziness, pain in extremities, joint pain, stomach pain, headache, sore nose and throat, rashes and bruising.
FAQs:
Q 1. How to use Azadual 100mg Injection?
Take Azadual 100mg Injection only under the supervision of the physician. Doctors will decide the dose based on the patient's height, weight, and general condition. Azadual 100mg Injection is administered under the skin of your thigh, stomach, or upper arm.
Q 2. Does Azadual 100mg Injection cause hair loss?
No, Azadual 100mg Injection does not cause hair loss even after using it for a prolonged period of time.
Q 3. How does Azadual 100mg Injection work?
Azadual 100mg Injection binds to RNA and DNA, interrupts their activity in actively multiplying cells, and exhibits a toxic effect on cancer cells.
Q 4. Is Azadual 100mg Injection chemotherapy?
Yes. Azadual 100mg Injection is chemotherapy used in the treatment of cancers. It interferes with the cell's DNA synthesis and decreases growth and multiplication (cytotoxic effect).
Q 5. What are the side effects of Azadual 100mg Injection?
The common side effects of Azadual 100mg Injection are nausea, vomiting, diarrhea, constipation, tiredness, decreased appetite, rashes, redness of the skin, dizziness, joint pain, headache, sore throat, and nose.
Q 6. Is it safe to drive after taking a Azadual 100mg Injection?
It is unsafe to drive after taking this injection as it causes dizziness and patients lack concentration and alertness. So, avoid driving and handling heavy machinery after taking this medication.
Fact Box:
Molecule name: Azacitidine
Therapeutic class: Anti-metabolites
Pharmacological class: Anti-Neoplastics
Indications:
Treat advanced or metastatic non-small lung cancer (NSCLC).
